Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by pcoopman
Group name EquipePC
Item Type Journal Article
Title Alu element insertion in the MLH1 exon 6 coding sequence as a mutation predisposing to Lynch syndrome
Creator Solassol et al.
Author Jérôme Solassol
Author Marion Larrieux
Author Julie Leclerc
Author Vincent Ducros
Author Carole Corsini
Author Pascal Pujol
Author Jean-Marc Rey
Abstract Lynch syndrome (LS) is the most frequent cause of hereditary colorectal cancer. A subset of patients with a history of LS shows no causal germline pathogenic alteration and are identified as having Lynch-like syndrome (LLS). Alu retrotransposons are the most abundant mobile DNA sequences in the human genome and have been associated with numerous human cancers by either disrupting coding regions or altering epigenetic modifications or splicing signals. We report a family first classified as having LLS by Sanger sequencing analysis. Next-generation sequencing (NGS) analysis identified an AluY5a insertion in MLH1 exon 6 that led to exon skipping. This splicing alteration inducing a pathogenic frameshift was found in patients who developed colorectal adenocarcinomas. Retroelement insertion might thus be an important but underestimated mechanism of cancer genetics that could be systematically tested in patients with a phenotype suggesting LS to accurately assess family risk and surveillance approaches. This article is protected by copyright. All rights reserved.
Publication Human Mutation
Date Feb 28, 2019
Journal Abbr Hum. Mutat.
Language eng
DOI 10.1002/humu.23725
ISSN 1098-1004
Library Catalog PubMed
Extra PMID: 30815977
Tags AluYa5, clinic, first-last-corresponding, Lynch-like syndrome, Mismatch repair deficiency, Retrotransposon, routine diagnosis
Date Added 2019/05/16 - 12:05:58
Date Modified 2023/11/20 - 16:44:06
Notes and Attachments PubMed entry (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés